Raymond James & Associates’s Global X Scientific Beta US ETF SCIU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-71,568
| Closed | -$2.22M | – | 3752 |
|
|
2020
Q2 | $2.22M | Sell |
71,568
-106,186
| -60% | -$3.22M | ﹤0.01% | 1671 |
|
|
2020
Q1 | $4.77M | Buy |
177,754
+9,875
| +6% | +$325K | 0.01% | 1077 |
|
|
2019
Q4 | $5.9M | Buy |
167,879
+1,396
| +0.8% | +$47.7K | 0.01% | 1156 |
|
|
2019
Q3 | $5.61M | Buy |
166,483
+39,138
| +31% | +$1.3M | 0.01% | 1153 |
|
|
2019
Q2 | $4.18M | Sell |
127,345
-3,451
| -3% | -$111K | 0.01% | 1327 |
|
|
2019
Q1 | $4.14M | Sell |
130,796
-3,490
| -3% | -$106K | 0.01% | 1292 |
|
|
2018
Q4 | $3.75M | Sell |
134,286
-3,307
| -2% | -$102K | 0.01% | 1240 |
|
|
2018
Q3 | $4.56M | Sell |
137,593
-8,409
| -6% | -$275K | 0.01% | 1274 |
|
|
2018
Q2 | $4.62M | Sell |
146,002
-1,961
| -1% | -$61.5K | 0.01% | 1235 |
|
|
2018
Q1 | $4.57M | Buy |
147,963
+1,786
| +1% | +$56K | 0.01% | 1201 |
|
|
2017
Q4 | $4.52M | Sell |
146,177
-2,630
| -2% | -$80.2K | 0.01% | 1178 |
|
|
2017
Q3 | $4.4M | Sell |
148,807
-5,011
| -3% | -$146K | 0.01% | 1153 |
|
|
2017
Q2 | $4.41M | Buy |
153,818
+6,414
| +4% | +$181K | 0.01% | 1087 |
|
|
2017
Q1 | $4.1M | Sell |
147,404
-9,416
| -6% | -$257K | 0.01% | 1116 |
|
|
2016
Q4 | $4.14M | Buy |
+156,820
| New | +$4.09M | 0.01% | 1083 |
|
Raymond James & Associates's SCIU Position: Q3 2020 in Review
Raymond James & Associates sold out of Global X Scientific Beta US ETF (SCIU) in Q3 2020, closing a stake of 71,568 shares — an estimated $2.22M sold.
Raymond James & Associates first reported a position in SCIU in Q4 2016 and held it in 15 quarters. The position peaked at $5.9M in Q4 2019. 0 funds tracked by Wall St. Rank hold SCIU as of Q3 2020.
- Raymond James & Associates reported no remaining Global X Scientific Beta US ETF position as of Q3 2020 after selling out during the quarter.
- Raymond James & Associates sold 71,568 Global X Scientific Beta US ETF shares in Q3 2020, an estimated $2.22M.
- Raymond James & Associates first reported a position in Global X Scientific Beta US ETF in Q4 2016 and held it in 15 quarters.
- Raymond James & Associates's Global X Scientific Beta US ETF position peaked at $5.9M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Global X Scientific Beta US ETF as of Q3 2020.
Based on Raymond James & Associates's 13F filing for Q3 2020, filed 4 Nov 2020.